IPP Bureau
Briefs: Alembic Pharma and IOL Chemicals and Pharmaceuticals
By IPP Bureau - March 07, 2025
USFDA inspection at Alembic Pharma's Bioequivalence facility
Medicamen Biotech partners with South African business conglomerate
By IPP Bureau - March 07, 2025
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
Lupin Launches Rivaroxaban Tablets USP, 2.5mg in US
By IPP Bureau - March 07, 2025
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
J. B. Chemicals & Pharmaceuticals announces DJSI score of 77
By IPP Bureau - March 06, 2025
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
Zydus receives final approval from USFDA for Dasatinib Tablets
By IPP Bureau - March 06, 2025
Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase
Zydus Lifesciences launches ANVIMO
By IPP Bureau - March 06, 2025
ANVIMO will be available in dosages of 240 mg and 480 mg
Auro Vaccines terminates license agreement with Hilleman Laboratories Singapore
By IPP Bureau - March 06, 2025
This termination of Agreement will not have any significant impact on the company and/or its subsidiaries or its financials
Need for enhancing capacity building of medical officers to achieve desired results of healthcare schemes at the grassroot level: J. P. Nadda
By IPP Bureau - March 05, 2025
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Unichem Laboratories receives 4 observations from USFDA for Pithampur API facility
By IPP Bureau - March 05, 2025
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Lucas Meyer Cosmetics by Clariant to launch honey-based skin repair solution ‘Melicica’
By IPP Bureau - March 05, 2025
Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
Natco Pharma appoints Bhimrao Dattu Jadhav as Senior VP – Operations (Formulations) for Pharma Division – Kothur
By IPP Bureau - March 04, 2025
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
Metropolis Healthcare to acquire Agra's Scientific Pathology
By IPP Bureau - March 04, 2025
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Zydus and Gates Foundation to develop world’s first combination vaccine to offer protection against shigellosis and typhoid
By IPP Bureau - March 04, 2025
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
